
Marchex heads into its third-quarter report with a revenue number that will look spectacular on paper and a stock price that suggests the market is not yet buying the story. The company closed its acquisition of Arcania on July 1, so this is the first period with the combined business fully on the books. That alone should push sales sharply higher. The real question is whether the cross-sell momentum management described three months ago is turning into durable, recurring revenue, or whether the headline growth is mostly arithmetic.
The Street is looking for revenue of about $16.2 million, up roughly 41% from $11.5 million a year ago and a big step up from the $11.0 million reported last quarter. Consensus sits comfortably inside management's guidance of $16.0 million to $16.5 million, just under the midpoint, so analysts are taking the company at its word without leaning into upside. Earnings are expected at $0.04 a share, with the whisper number a penny higher at $0.05. That gap is small, but for a company that lost a penny last quarter and two cents a year ago, it hints that some investors expect the combined profit profile to land on the better side of plan. Management also guided adjusted EBITDA to $2.3 million to $2.5 million, implying an annualized run rate near $10 million, and that figure may matter more than EPS in judging whether the merged cost structure is working.
The last call was the most confident Marchex has delivered in some time. Management moved from talking about potential to naming dollars: a home services customer expanding from roughly $500,000 to more than $1 million on AI-verified outcomes, an auto services pilot growing from 40 to more than 60 locations with seven-figure potential, and an advertising and media customer running a $400,000 paid pilot for a conversational AI agent that could expand meaningfully in 2027. Executives also said a double-digit number of customers carry seven-figure incremental potential. Validation this quarter would look like updates showing those pilots converting into contracted, recurring deployments, plus new names joining the list. A challenge would come if the examples stay the same, if conversion timelines slip, or if the legacy business resumes the erosion it showed through much of 2025.
Cash deserves attention too. Balances slid from $10.3 million a year ago to $8.2 million last quarter, which management attributed to transaction and realignment costs. With those expenses largely behind it and EBITDA expected to turn solidly positive, the cash line should stabilize. If it keeps falling while the company makes the selective sales and development investments it flagged for 2027 growth, the financial cushion becomes a sharper concern for a small company with heavy customer concentration, where the top 100 accounts generate about 90% of revenue.
Sentiment has swung notably, from a bearish lean ahead of the last report to a clearly bullish one now. The stock has not followed. Shares have fallen about 15.6% since the previous report, trailing the S&P 500 by nearly 13 percentage points, and at $1.46 they sit below the 200-day moving average of $1.58 and in the lower half of a wide $1.15 to $2.00 post-earnings range. That disconnect suggests the market may be discounting the Arcania lift as mechanical and waiting for organic evidence, though a thinly traded stock can move for many reasons.
Hitting the revenue guide is close to table stakes. What will determine whether the improving narrative holds is whether Marchex can show that its seven-figure pipeline is converting into recurring contracts while the combined company delivers the promised EBITDA and stops the cash drain. Clear progress on those fronts, along with a credible fourth-quarter outlook, would give skeptical holders a reason to reassess.
This earnings preview was originally published on Earnings Whispers.
This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.
| Nov-03 | |
| Oct-30 | |
| Oct-29 | |
| Oct-27 | |
| Oct-08 | |
| Sep-28 | |
| Sep-22 | |
| Sep-21 | |
| Sep-16 | |
| Sep-08 | |
| Aug-26 | |
| Aug-24 | |
| Aug-13 | |
| Aug-12 | |
| Aug-12 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite